Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Change of NLRP3 Inflammasome Expression Level, Symptoms, and Functional Status in Patients With Heart Failure With Preserved Ejection Fraction Treated With ARNI

NCT04269057 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.

NCT NCT04269057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Change of NLRP3 Inflammasome Expression Level, Symptoms, and Functional Status in Patients With Heart Failure With Preserved Ejection Fraction Treated With ARNI
Lead sponsor
Chongqing Medical University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 1, 2020
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure